(Q54671979)

2 June 2018

title

Intermediate-stage HCC--upfront resection can be feasible. (English)

1 reference

2 June 2018

author

Jian-Hong Zhong

1

1 reference

2 June 2018

author name string

Shi-Dong Lu

2

1 reference

2 June 2018

Yan-Yan Wang

3

1 reference

2 June 2018

Liang Ma

4

1 reference

2 June 2018

Le-Qun Li

5

1 reference

2 June 2018

language of work or name

English

0 references

publication date

7 April 2015

1 reference

2 June 2018

Nature Reviews Clinical Oncology

published in

1 reference

2 June 2018

volume

12

1 reference

2 June 2018

issue

5

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2014.122-c3

exact match

0 references

cites work

Treatment of intermediate-stage hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Prognosis of hepatocellular carcinoma: the BCLC staging classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.122-C3

10.1038/NRCLINONC.2014.122-C3

31 March 2020

Identifiers

DOI

1 reference

2 June 2018

Dimensions Publication ID

1049198626

0 references

1 reference

2 June 2018